Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by 3DHEALS. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by 3DHEALS or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Episode #89 | The Bioprinting Frontier (Live Recording)

1:39:50
 
Share
 

Manage episode 496312003 series 2901571
Content provided by 3DHEALS. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by 3DHEALS or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

The future of medicine is growing closer to recreating the very building blocks of life itself. In this groundbreaking discussion, four bioprinting experts reveal how their technologies are moving rapidly from laboratory concepts to clinical realities that could forever change how we treat disease.
Mike Graffeo, the CEO and co-founder of FluidForm Bio, shares the group's remarkable progress toward eliminating insulin injections for type 1 diabetes patients. Their FRESH 3D bioprinting technology creates implants that produce insulin naturally in response to blood glucose. "Life should not come with a needle," Graffeo emphasizes, highlighting how their approach could deliver a functional cure.

Other leaders in bioprinting go on to share their unqiue approaches to 3D innovation in medicine. Annaliese Vojnich, Business Development and Technical Sales Manager at ViscoTec America, demonstrates how Puredyne's progressive cavity pump technology achieves precise extrusion while maintaining cell viability.

Dr. Jorge Madrid-Wolff, Application Scientist, reveals Readily3D's volumetric printing, which creates complex structures in seconds rather than hours, enabling functional mammary gland models that produce milk proteins and beating cardiac tissue. Dr. Karolina Valente, Founder and CEO, explains how VoxCell BioInnovation's vascularized tissue models are addressing the 95% failure rate of oncology drugs in clinical trials by providing more translatable data than animal testing.
Ready to witness firsthand how bioprinting is transforming from science fiction into medical reality? This discussion provides both the scientific foundations and practical pathways that will bring these revolutionary technologies from laboratory benches to hospital bedsides within the next decade.

Sound Engineer: Faith Fernandes

Event On-Demand

Send us a text

Support the show

Subscribe to our premium version and support the show.

Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel

About Pitch3D

  continue reading

Chapters

1. Introduction to Bioprinting (00:00:00)

2. Mike Graffeo: FluidForm's Type 1 Diabetes Solution (00:03:46)

3. Annaliese Vojnich: Puredyne by ViscoTec for Bioprinting (00:25:53)

4. Dr. Jorge Madrid-Wolff: Readily3D's Volumetric Bioprinting (00:40:16)

5. Dr. Karolina Valente: VoxCell BioInnovation's Vascularized Tissue Models (01:01:09)

6. Panel Discussion: Form vs. Function and Future Outlook (01:21:43)

7. Q&A and Closing Remarks (01:35:01)

27 episodes

Artwork
iconShare
 
Manage episode 496312003 series 2901571
Content provided by 3DHEALS. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by 3DHEALS or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

The future of medicine is growing closer to recreating the very building blocks of life itself. In this groundbreaking discussion, four bioprinting experts reveal how their technologies are moving rapidly from laboratory concepts to clinical realities that could forever change how we treat disease.
Mike Graffeo, the CEO and co-founder of FluidForm Bio, shares the group's remarkable progress toward eliminating insulin injections for type 1 diabetes patients. Their FRESH 3D bioprinting technology creates implants that produce insulin naturally in response to blood glucose. "Life should not come with a needle," Graffeo emphasizes, highlighting how their approach could deliver a functional cure.

Other leaders in bioprinting go on to share their unqiue approaches to 3D innovation in medicine. Annaliese Vojnich, Business Development and Technical Sales Manager at ViscoTec America, demonstrates how Puredyne's progressive cavity pump technology achieves precise extrusion while maintaining cell viability.

Dr. Jorge Madrid-Wolff, Application Scientist, reveals Readily3D's volumetric printing, which creates complex structures in seconds rather than hours, enabling functional mammary gland models that produce milk proteins and beating cardiac tissue. Dr. Karolina Valente, Founder and CEO, explains how VoxCell BioInnovation's vascularized tissue models are addressing the 95% failure rate of oncology drugs in clinical trials by providing more translatable data than animal testing.
Ready to witness firsthand how bioprinting is transforming from science fiction into medical reality? This discussion provides both the scientific foundations and practical pathways that will bring these revolutionary technologies from laboratory benches to hospital bedsides within the next decade.

Sound Engineer: Faith Fernandes

Event On-Demand

Send us a text

Support the show

Subscribe to our premium version and support the show.

Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel

About Pitch3D

  continue reading

Chapters

1. Introduction to Bioprinting (00:00:00)

2. Mike Graffeo: FluidForm's Type 1 Diabetes Solution (00:03:46)

3. Annaliese Vojnich: Puredyne by ViscoTec for Bioprinting (00:25:53)

4. Dr. Jorge Madrid-Wolff: Readily3D's Volumetric Bioprinting (00:40:16)

5. Dr. Karolina Valente: VoxCell BioInnovation's Vascularized Tissue Models (01:01:09)

6. Panel Discussion: Form vs. Function and Future Outlook (01:21:43)

7. Q&A and Closing Remarks (01:35:01)

27 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play